Before you sell to, join or invest in FORE US Bio Inc.
MentionFox check on FORE US Bio Inc.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/fore-us-bio-inc-form-d-25000001
Check FORE US Bio Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about FORE US Bio Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
FORE US Bio Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-05-15.
FORE US Bio Inc. filed an amended Form D notice of an exempt securities offering with the SEC on May 15, 2025. The filing reports $70.41M sold. Its industry group is Biotechnology. It names William Hinshaw (Executive Officer, Director), Erez Chimovits (Director), Dieter Weinand (Director) (SEC Form D/A, May 15, 2025).
Is this your company?
Sell to companies like FORE US Bio Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-15 · the record
Pitching, partnering or investing alongside them? See who really runs and owns FORE US Bio Inc.
Free to see. No signup.
More on the people and the money behind FORE US Bio Inc., from the filings we hold.
Biotechnology raises by companies based in Pennsylvania, filed within 90 days of this one, largest first.
Get an email when FORE US Bio Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when FORE US Bio Inc. raises, hires or launches. No email unless you switch it on.
Watch FORE US Bio Inc. →Get the full cited report on FORE US Bio Inc.
What the filing shows about FORE US Bio Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on FORE US Bio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives FORE US Bio Inc.'s address as 3675 Market Street, Suite 200, Philadelphia, PA 19104.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for FORE US Bio Inc. →
Amended on 2026-07-14: the offering size changed from $46,024,857 to $109,619,395; the amount sold changed from $37,443,239 to $70,410,173; the number of investors changed from 9 to 20. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
FORE US Bio Inc. is a registered filer with the SEC (CIK 1990659) and has filed since 2023-08-24. 3 filings are on record, the latest on 2026-07-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
FORE US Bio Inc.'s Form D of 2025-05-15 names William Hinshaw, Erez Chimovits, Dieter Weinand and 5 more as its officers, directors or promoters.
Its new offerings report $99.52M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
William Hinshaw is named as Executive Officer and Director on the Form D that FORE US Bio Inc. filed with the SEC on 15 May 2025, one of 8 people that filing names.
Erez Chimovits is named as Director on the Form D that FORE US Bio Inc. filed with the SEC on 15 May 2025, one of 8 people that filing names.
Dieter Weinand is named as Director on the Form D that FORE US Bio Inc. filed with the SEC on 15 May 2025, one of 8 people that filing names.
Chandra Leo is named as Director on the Form D that FORE US Bio Inc. filed with the SEC on 15 May 2025, one of 8 people that filing names.
Rajeev Dadoo is named as Director on the Form D that FORE US Bio Inc. filed with the SEC on 15 May 2025, one of 8 people that filing names.
Giovanni Mariggi is named as Director on the Form D that FORE US Bio Inc. filed with the SEC on 15 May 2025, one of 8 people that filing names.
On the filing as: Executive Officer.
Michael Byrnes is named as Chief Financial Officer on the Form D that FORE US Bio Inc. filed with the SEC on 15 May 2025, one of 8 people that filing names.
Kim Blackwell is named as Director on the Form D that FORE US Bio Inc. filed with the SEC on 15 May 2025, one of 8 people that filing names.
8 people named on the filing — 2 holding an executive role and 6 as directors only.
Named as of the 2025-05-15 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about FORE US Bio Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on FORE US Bio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on FORE US Bio Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist FORE US Bio Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind FORE US Bio Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for FORE US Bio Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Philadelphia
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/fore-us-bio-inc-form-d-25000001